Novartis Institutes for BioMedical Research, Inc. is 10% Owner at Intellia Therapeutics, Inc. (NTLA). They have made 3 open-market trades across 2 companies since 2016, most recently 2018-04-23.
CIK 0001652130
2 open-market purchases totalling $16.5M since 2016, against 1 sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.